Showing results (101-110 of 250) with videos related to
Sort By:
Pageof 25
The Journal of Clinical Investigation|June 20, 2018
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cellsThemis Alissafi, Aikaterini Hatzioannou, Konstantinos Mintzas, et al.American Journal of Therapeutics|November 2, 2013
Who benefits most from adjuvant interferon treatment for melanoma?Helen Gogas, Huseyin Abali, Paolo A Ascierto, et al.Anticancer Research|June 13, 2014
Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assayAristeidis G Vaiopoulos, Ioannis D Kostakis, Eliona Gkioka, et al.American Journal of Clinical Oncology|December 13, 2002
Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2BHelen Gogas, George Paterakis, Konstantina Frangia, et al.Medical Oncology (Northwood, London, England)|September 18, 2007
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II studyThomas Makatsoris, Pavlos Papakostas, Haralabos P Kalofonos, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.Cancer Investigation|December 8, 2004
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)George Fountzilas, Christos Christodoulou, Dimitrios Tsavdaridis, et al.Cancer|June 16, 2010
Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferonHelen Gogas, John M Kirkwood, Christine S Falk, et al.Cancers|August 12, 2022
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with ImmunotherapyPanagiotis T Diamantopoulos, Christina-Nefeli Kontandreopoulou, Aikaterini Gkoufa, et al.Journal of Neuroendocrinology|November 17, 2025
Magnetic resonance imaging features of hypophysitis in patients with cancer treated with immune checkpoint inhibitorsAnna Angelousi, Stavroula Asimakopoulou, Charis Bourgioti, et al.Pageof 25